source
- STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and moreThe Novartis CEO warned that Trump's drug pricing policy poses a “very difficult situation” and the reality will soon catch up with drugmakers and patientsSTAT · 3mo ago↗ source
- Coultreon banks $125M to support testing of former Galapagos immune drugBacked by Novo Holdings, Regeneron’s venture arm and several others, the biotech believes an oral drug licensed from Galapagos might hold potential treating many immunological diseases.BioPharma Dive · 3mo ago↗ source
- Predicting consequences of new hepatitis B vaccine recsNew data on public trust in science, AI and mental health, and other news from Morning RoundsSTAT · 3mo ago